Results 91 to 100 of about 9,717,714 (304)

Significance of Maternal and Cord Blood Nucleated Red Blood Cell Count in Pregnancies Complicated by Preeclampsia

open access: yesJournal of Pregnancy, 2014
Objectives. To evaluate the effect of preeclampsia on the cord blood and maternal NRBC count and to correlate NRBC count and neonatal outcome in preeclampsia and control groups. Study Design.
Shripad Hebbar, Mehak Misha, Lavanya Rai
doaj   +1 more source

Association of Complete Blood Count Parameters with Gestational Diabetes Mellitus

open access: yesGynecology Obstetrics & Reproductive Medicine, 2017
Objective: The aim of this study is to evaluate the relationship between hematological changes in early pregnancy using complete blood count parameters and gestational diabetes mellitus.
Zehra Vural Yılmaz   +3 more
doaj   +1 more source

CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. [PDF]

open access: yes, 2012
BACKGROUND: Most adults infected with HIV achieve viral suppression within a year of starting combination antiretroviral therapy (cART). It is important to understand the risk of AIDS events or death for patients with a suppressed viral load.
S. Matheron   +182 more
core   +2 more sources

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

Preliminary evaluation of complete blood cell count on Mindray BC-6800.

open access: yes, 2013
Preliminary evaluation of complete blood cell count on Mindray BC ...
AVERSA, Franco   +7 more
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Correlation between bronchoalveolar lavage total white blood cell count and APACHE II score.

open access: yes, 2014
Correlation between bronchoalveolar lavage total white blood cell count and APACHE II score.
Chae-Man Lim (91681)   +12 more
core   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Assessment of medullary response through cellular immaturity parameters in patients undergoing hematopoietic stem cell transplantation [PDF]

open access: yesEinstein (São Paulo)
Objective: This study aimed to evaluate relative immature platelet fraction (IPF%), absolute immature platelet fraction (A-IPF), and relative immature reticulocyte fraction (IRF%) as biomarkers of bone marrow recovery after hematopoietic stem cell ...
Bruno Gabriel Nardini Fogo   +6 more
doaj   +2 more sources

Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma

open access: yes, 2022
Background. The treatment and prognosis of metastatic melanoma have changed during the last decade to include immunotherapy or targeted therapy as standard therapeutic options for BRAF-mutated melanoma.
Ondrej Kubecek   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy